Skip to content

Clinical study on the effect of cardiac rehabilitation training on chest pain in patients with ischemic non obstructive coronary heart disease - single center, prospective, randomized controlled trial

Clinical study on the effect of cardiac rehabilitation training on chest pain in patients with ischemic non obstructive coronary heart disease - single center, prospective, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096894
Enrollment
Unknown
Registered
2025-02-08
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non obstructive coronary heart disease

Interventions

Intervention group:Combining conventional drug therapy with cardiac rehabilitation training
Control group:Conventional drug therapy

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-75 years old; (2) Patients with confirmed diagnosis of INOCA, the diagnostic criteria for INOCA are: 1) Symptoms of myocardial ischemia, angina pectoris, exertional dyspnea during exertion or at rest; 2) no obstructive coronary artery disease (coronary artery stenosis confirmed by coronary angiography or coronary CTA examination <50%); 3) Evidence of coronary microcirculatory disorders: myocardial stress perfusion scan (CT-MPI) examination determined myocardial blood flow (MBF) <100; (3) No limitation of mobility, able to complete cardiopulmonary exercise test; (4) Ability to use a smartphone; (5) Able to cooperate with the completion of the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Presence of valvular heart disease (aortic stenosis, aortic regurgitation, etc.), (2) cardiomyopathy (hypertrophic, dilated, restrictive, etc.), (3) 50% of patients with EF < cardiac ultrasound, (4) Central nervous system disease (hemorrhagic stroke, ischemic stroke) or undergoing intracranial or spinal cord surgery, (5) Malignant tumors or expected survival time of less than 1 year; (6) The subject is not suitable to participate in this trial (such as suffering from motor restriction diseases); (7) Populations that are unable to understand and/or comply with the procedures of this study (such as patients with alcoholism, drug abuse, or psychiatric disorders); (8) People who are participating in clinical trials of other devices or drugs and have not met the primary endpoint; (9) researchers involved in the design and execution of this study.

Design outcomes

Primary

MeasureTime frame
Seattle Angina Questionnaire (SAQ);

Secondary

MeasureTime frame
Readmission due to angina attack;Anxiety levels;Depression levels;Quality of life situation;Sleep quality;

Countries

China

Contacts

Public ContactJian Wu

The Second Affiliated Hospital of Harbin Medical University

wujian780805@163.com+86 152 4500 1123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026